FDA Clearance Tracker · K253061
Portable Neuromodulation Stimulator (PoNS)
Last checked: Nov 20, 2026Latest source record: May 13, 2026 (this decision)Source: openFDAMethods & limitations
Decided
May 13, 2026
Substantially Equivalent
Time to decision
233 days
Received Sep 22, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K253061
- Device name
- Portable Neuromodulation Stimulator (PoNS)
- Applicant
- Helius Medical, Inc.
- Applicant location
- Newton, PA
- Received
- Sep 22, 2025
- Decided
- May 13, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 882.5889
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QCF. The earliest in FDA's data is DEN200050, decided Mar 26, 2021.
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
- FDA database record for K253061
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Helius Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Portable Neuromodulation Stimulator (PoNS)New device typeBreakthroughDe Novo
DEN200050 · Decided Mar 26, 2021 · 234 days after receipt
Device type: Electrical Tongue Stimulator To Treat Motor Deficits (QCF) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.